These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 25174923)

  • 1. Peptide deformylase: a new target in antibacterial, antimalarial and anticancer drug discovery.
    Sangshetti JN; Khan FA; Shinde DB
    Curr Med Chem; 2015; 22(2):214-36. PubMed ID: 25174923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacterial Peptide deformylase inhibitors: a new class of antibacterial agents.
    Jain R; Chen D; White RJ; Patel DV; Yuan Z
    Curr Med Chem; 2005; 12(14):1607-21. PubMed ID: 16022661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic potential of peptide deformylase inhibitors.
    Chen D; Yuan Z
    Expert Opin Investig Drugs; 2005 Sep; 14(9):1107-16. PubMed ID: 16144495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structures of Staphylococcus aureus peptide deformylase in complex with two classes of new inhibitors.
    Lee SJ; Lee SJ; Lee SK; Yoon HJ; Lee HH; Kim KK; Lee BJ; Lee BI; Suh SW
    Acta Crystallogr D Biol Crystallogr; 2012 Jul; 68(Pt 7):784-93. PubMed ID: 22751663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligand and Structure-Based Approaches for the Identification of Peptide Deformylase Inhibitors as Antibacterial Drugs.
    Gao J; Liang L; Zhu Y; Qiu S; Wang T; Zhang L
    Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27428963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptide deformylase as an antibacterial target: a critical assessment.
    Leeds JA; Dean CR
    Curr Opin Pharmacol; 2006 Oct; 6(5):445-52. PubMed ID: 16904375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The evolution of peptide deformylase as a target: contribution of biochemistry, genetics and genomics.
    Yuan Z; White RJ
    Biochem Pharmacol; 2006 Mar; 71(7):1042-7. PubMed ID: 16289392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, antibacterial activity, and biological evaluation of formyl hydroxyamino derivatives as novel potent peptide deformylase inhibitors against drug-resistant bacteria.
    Yang S; Shi W; Xing D; Zhao Z; Lv F; Yang L; Yang Y; Hu W
    Eur J Med Chem; 2014 Oct; 86():133-52. PubMed ID: 25151577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptide deformylase inhibitors with non-peptide scaffold: synthesis and structure-activity relationships.
    Lee SK; Choi KH; Lee SJ; Lee JS; Park JY; Kim BM; Lee BJ
    Bioorg Med Chem Lett; 2011 Jan; 21(1):133-6. PubMed ID: 21146987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrocyclic inhibitors for peptide deformylase: a structure-activity relationship study of the ring size.
    Hu X; Nguyen KT; Jiang VC; Lofland D; Moser HE; Pei D
    J Med Chem; 2004 Sep; 47(20):4941-9. PubMed ID: 15369398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a human peptide deformylase: implications for antibacterial drug design.
    Nguyen KT; Hu X; Colton C; Chakrabarti R; Zhu MX; Pei D
    Biochemistry; 2003 Aug; 42(33):9952-8. PubMed ID: 12924944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide deformylase inhibitors with retro-amide scaffold: synthesis and structure-activity relationships.
    Lee SK; Choi KH; Lee SJ; Suh SW; Kim BM; Lee BJ
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4317-9. PubMed ID: 20615695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Peptide-deformylase inhibitors, a new class of antibiotics].
    Dubreuil L
    Presse Med; 2002 Nov; 31(38):1810-2. PubMed ID: 12497724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Discovery of Antibacterial Natural Compound Based on Peptide Deformylase.
    Liang L; Zhou Q; Hao Z; Wang F; Zhu Y; Lin Q; Gao J
    Comb Chem High Throughput Screen; 2018; 21(4):292-297. PubMed ID: 29468960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel approaches to antimicrobial therapy: peptide deformylase.
    Waller AS; Clements JM
    Curr Opin Drug Discov Devel; 2002 Sep; 5(5):785-92. PubMed ID: 12630299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PDF inhibitors: an emerging class of antibacterial drugs.
    Johnson KW; Lofland D; Moser HE
    Curr Drug Targets Infect Disord; 2005 Mar; 5(1):39-52. PubMed ID: 15777197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide deformylase as an antibacterial drug target: target validation and resistance development.
    Apfel CM; Locher H; Evers S; Takács B; Hubschwerlen C; Pirson W; Page MG; Keck W
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1058-64. PubMed ID: 11257016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, Synthesis, and Biological Evaluation of Vanillin Hydroxamic Acid Derivatives as Novel Peptide Deformylase Inhibitors.
    Gao J; Qiu S; Liang L; Hao Z; Zhou Q; Wang F; Mou J; Lin Q
    Curr Comput Aided Drug Des; 2018; 14(1):95-101. PubMed ID: 28606047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biphenyl tetrazole-thiazolidinediones as novel bacterial peptide deformylase inhibitors: Synthesis, biological evaluations and molecular docking study.
    Khan FAK; Jadhav KS; Patil RH; Shinde DB; Arote RB; Sangshetti JN
    Biomed Pharmacother; 2016 Oct; 83():1146-1153. PubMed ID: 27551762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic activity and characterization of BB-3497, a novel peptide deformylase inhibitor.
    Clements JM; Beckett RP; Brown A; Catlin G; Lobell M; Palan S; Thomas W; Whittaker M; Wood S; Salama S; Baker PJ; Rodgers HF; Barynin V; Rice DW; Hunter MG
    Antimicrob Agents Chemother; 2001 Feb; 45(2):563-70. PubMed ID: 11158755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.